Showing results (21-30 of 191) with videos related to
Sort By:
Pageof 20
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 20, 2015
Efficacy and safety of pegylated interferon plus ribavirin for the treatment of hepatitis C virus-positive cryoglobulinemic glomerulonephritisCesare Mazzaro, Giacomo Panarello, Endri Mauro, et al.Investigational New Drugs|February 5, 2010
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell linesClaudio Celeghini, Rebecca Voltan, Erika Rimondi, et al.Methods in Molecular Biology (Clifton, N.J.)|October 24, 2018
Methods for Investigating VLA-4 (CD49d/CD29) Expression and Activation in Chronic Lymphocytic Leukemia and Its Clinical ApplicationsAntonella Zucchetto, Erika Tissino, Alexander Chigaev, et al.British Journal of Haematology|April 26, 2002
Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's diseaseAntonino Carbone, Annunziata Gloghini, Donatella Aldinucci, et al.Haematologica|August 1, 2020
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemiaGiovanni Del Poeta, Annalisa Biagi, Luca Laurenti, et al.Experimental Hematology|November 9, 2002
CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blastsDonatella Aldinucci, Dalisa Poletto, Paola Nanni, et al.Blood|September 27, 2013
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanismAntonella Zucchetto, Chiara Caldana, Dania Benedetti, et al.Haematologica|October 30, 2020
<i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulationFederico Pozzo, Tamara Bittolo, Erika Tissino, et al.Hematological Oncology|November 16, 2021
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemiaErika Tissino, Eliana Pivetta, Alessandra Capuano, et al.Hematological Oncology|September 3, 2021
Hepatitis C virus-associated indolent B-cell lymphomas: A review on the role of the new direct antiviral agents therapyCesare Mazzaro, Luigino Dal Maso, Marcella Visentini, et al.Pageof 20